Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Chubb
UBS
Moodys
Covington
McKinsey
Cipla
McKesson

Generated: April 24, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: dexlansoprazole

« Back to Dashboard

dexlansoprazole

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Takeda Pharms Usa DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287 NDA Cardinal Health N 55154-5154-8
Takeda Pharms Usa DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287 NDA Cardinal Health N 55154-5154-2
Takeda Pharms Usa DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287 NDA Takeda Pharmaceuticals America, Inc. N 64764-171-11
Takeda Pharms Usa DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287 NDA Takeda Pharmaceuticals America, Inc. N 64764-171-19
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Julphar
Fish and Richardson
Teva
Medtronic
Johnson and Johnson
Healthtrust
Fuji